New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For SI;GSK;UBS;NOK;FLO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
06:05 EDTNOKNokia inks four-year deal with Bharti Airtel India for 3G network rollout
Subscribe for More Information
June 28, 2015
18:08 EDTNOKElliott takes roughly 1.3% stake in Alcatel-Lucent, FT says
Subscribe for More Information
June 26, 2015
16:17 EDTNOKInterDigital: ITC to review RID involving Nokia and Microsoft
Subscribe for More Information
10:38 EDTGSKCourt revives lawsuit over GlaxoSmithKline Lamictal drug, Bloomberg reports
Subscribe for More Information
05:51 EDTNOKFoxconn expects to be largest handset, tablet ODM/OEM in 2015, DigiTimes says
Foxconn Chairman Terry Guo said the company is set to be the largest OEM/ODM for handsets, tablets and desktops in 2015, reports DigiTimes. Guo added that Foxconn will establish component supply chains to increase its advantage over competitors. Reference Link
June 25, 2015
14:01 EDTGSKGlaxoSmithKline initiated with a Buy at HSBC
Price target GBP 17.
06:31 EDTNOKMicrosoft focusing on increasing smartphone sales in India, WSJ reports
Subscribe for More Information
June 24, 2015
13:37 EDTGSKGSK says CDC committee votedfor meningococcal group B vaccines
GlaxoSmithKline (GSK) announced that the U.S. Centers for Disease Control Advisory Committee on Immunization Practices voted for a Category B recommendation for meningococcal group B vaccination, including Bexsero, in individuals aged 16 to 23. Bexsero was approved by the FDA in January for use in individuals aged 10 through 25 years and acquired by GSK in March following the closure of the three-part transaction with Novartis (NVS).
June 23, 2015
07:25 EDTGSKPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
June 22, 2015
11:04 EDTNOKNokia says HERE expanding real-time traffic service to 50 countries
Subscribe for More Information
07:17 EDTNOKRegulators to decide by July 27 on Nokia, Alcatel-Lucent deal, Reuters reports
Subscribe for More Information
07:01 EDTGSKPfizer to acquire Nimenrix, Mencevax from GlaxoSmithKline for $130M
Pfizer (PFE) announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130M. This transaction will add two high-quality and complementary vaccines to Pfizer’s portfolio, allowing the company to reach a broader global population. Nimenrix is a single dose meningococcal ACWY-TT conjugated vaccine designed to protect against Neisseria meningitidis, an uncommon but highly contagious disease that can lead to disability and death. Mencevax is a single-dose meningococcal ACWY unconjugated polysaccharide vaccine used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic or highly epidemic. Pfizer does not expect this transaction to have any significant impact on its 2015 financial performance. The transaction is subject to customary closing conditions as well as regulatory approvals in several markets, and is expected to occur in the second half of 2015. Pfizer’s legal advisors for the transaction were Ropes & Gray and Clifford Chance.
June 18, 2015
19:08 EDTNOKNokia CEO confirms plan to launch new smartphone line, BGR says
Subscribe for More Information
13:08 EDTGSKGlaxoSmithKline management to meet with Piper Jaffray
Meeting to be held in Minneapolis on June 23 hosted by Piper Jaffray.
07:50 EDTUBSSNB pushes UBS, Credit Suisse to improve leverage ratios
Subscribe for More Information
June 17, 2015
18:39 EDTNOKNokia looks to German carmakers as it seeks $4B for map unit, Bloomberg says
Subscribe for More Information
17:37 EDTUBSGM hires advisers as Fiat Chrysler tries to force merger talks, Reuters says
Subscribe for More Information
11:03 EDTNOKNokia, Alcatel-Lucent say DOJ permits companies to proceed with combination
Nokia (NOK) and Alcatel-Lucent (ALU) announced that the U.S. Department of Justice has granted early termination of the U.S. antitrust waiting period for the combination of Nokia and Alcatel-Lucent, permitting the transaction to proceed. The parties said they continue to make good progress with the regulatory approval processes in the remaining relevant jurisdictions, with the parties having already obtained antitrust clearances in Brazil and Serbia. The transaction remains subject to approval by Nokia shareholders, Nokia holding over 50% of the share capital of Alcatel-Lucent on a fully diluted basis upon completion of the public exchange offer, receipt of other regulatory approvals and other customary conditions. The transaction is expected to close in the first half of 2016.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use